Showing results (1551-1560 of 6,720) with videos related to

Sort By:
Pageof 672
Annals of Hematology|June 10, 2026
A model to estimate spleen volume from palpated spleen length in patients with myelofibrosisAlbert Assad, Sue Erickson-Viitanen, J E Hamer-Maansson, et al.
Annals of Hematology|May 1, 2026
CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemiaJinhong Nie, Lu Gao, Yingchun Shao, et al.
Annals of Hematology|June 1, 2026
Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in JapanMitsuhiro Itagaki, Hiroshi Kuwazawa, Shun Sasaki, et al.
Annals of Hematology|June 2, 2026
IGHV mutational status and BCR stereotypy in chronic lymphocytic leukemia: A Turkish cohort analysisSeher Yüksel, Rahmi Şinasi Aygün, Merve Yüksel, et al.
Annals of Hematology|June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantationStefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Annals of Hematology|June 5, 2026
In mantle cell lymphoma, whether 18 F-FDG PET/CT or flow cytometry provide superior diagnostic performance compared to biopsy in the determination of bone marrow involvement and enhance prognostic predictive valueDi Wang, Haochen Wu, MengHan Li, et al.
Annals of Hematology|October 3, 2023
Pathophysiology and management of iron deficiency anaemia in pregnancy: a reviewJ P Akshay Kirthan, Manjunath S Somannavar
Annals of Hematology|March 3, 2007
Zinc protoporphyrin, a useful parameter to address hyperferritinemiaGeorgia Metzgeroth, Beate Schultheis, Alexandra Dorn-Beineke, et al.
Annals of Hematology|June 13, 2026
Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 studyHongyan Tong, Zenghua Lin, Chen Yang, et al.
Annals of Hematology|June 23, 2010
Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trialCornelius F Waller, Miguel Bronchud, Stuart Mair, et al.
Pageof 672